Essbio S.A. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CLP 65,832.16 million compared to CLP 59,532.69 million a year ago. Net income was CLP 11,451.24 million compared to CLP 11,674.83 million a year ago.

Basic earnings per share from continuing operations was CLP 0.43 compared to CLP 0.44 a year ago.